Astrazeneca (AZN) EBITDA Margin (2009 - 2026)
Astrazeneca (AZN) posted EBITDA Margin of 39.77% for Q3 2026, up 4.05 percentage points from 35.73% a year earlier and up 6.67 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBITDA Margin at Astrazeneca was 35.68%, up 0.52 percentage points year-over-year; for FY2025, it was 33.16%, up 2.29 percentage points from FY2024.
- Annual EBITDA Margin has increased for four consecutive years, with a five-year change of +1.93 percentage points (FY2020 to FY2025).
- In prior years, Astrazeneca's EBITDA Margin was 30.87% in FY2024 (+1.22 pp), 29.64% in FY2023 (+8.82 pp), 20.83% in FY2022 (+0.55 pp) and 20.27% in FY2021 (-10.95 pp).
- The Q3 2026 figure stands as the highest quarterly EBITDA Margin since Q4 2019.
- On a year-over-year basis, EBITDA Margin increased in five of the last seven quarters, with an average year-over-year change of +1.82 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2023, with a gain of 19.14 percentage points; the weakest was Q1 2022, with a drop of 17.89 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 33.11% (Q2 2026), 39.01% (Q1 2026) and 30.88% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 22.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 39.77% |
| Jun 30, 2026 | 33.11% |
| Mar 31, 2026 | 39.01% |
| Dec 31, 2025 | 30.88% |
| Sep 30, 2025 | 35.73% |
| Jun 30, 2025 | 33.87% |
| Mar 31, 2025 | 38.51% |
| Dec 31, 2024 | 32.73% |
| Sep 30, 2024 | 30.30% |
| Jun 30, 2024 | 31.11% |
| Mar 31, 2024 | 35.89% |
| Jun 30, 2023 | 32.69% |
| Mar 31, 2023 | 38.34% |
| Jun 30, 2022 | 17.60% |
| Mar 31, 2022 | 19.20% |
| Dec 31, 2021 | 16.52% |
| Sep 30, 2021 | 11.44% |
| Jun 30, 2021 | 22.87% |
| Mar 31, 2021 | 37.10% |
| Dec 31, 2020 | 32.58% |
API Access
Astrazeneca EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();